OnkoGenetiks offers a comprehensive hereditary cancer screening panel, analyzing 275 genes associated with various cancers. Utilizing next-generation sequencing, this panel efficiently targets specific genes and mutations, detecting even low-frequency variations. It provides a broad analysis of the cancer genome, maximizing the chance of identifying clinically relevant alterations and expanding treatment options.
Who Should Consider the OnkoGenetiks Hereditary Cancer Test?
- Individuals with a personal history of early-onset or multiple primary cancers.
- Those with a family history of cancer across multiple generations.
- Individuals where a single targeted panel doesn't cover the suspected familial cancer risk.
OnkoGenetiks Comprehensive Cancer Screening test panel covers a total of 275 genes associated with several cancers including breast, ovary, uterus, prostate, gastric and colorectal.
For more information download the PDF brochure
